Mari-Liis Kaljusto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Mari-Liis Kaljusto has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Jarle Vaage
N/a, Oslo University Hospital, Oslo, Norway
4 shared publications- Kåre-Olav Stensløkken
University of Oslo
3 shared publications - Theis Tønnessen
Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Oslo, Norway
3 shared publications Guro Valen
Institute of Basic Medical Science, Department of Physiology, University of Oslo, Oslo, Norway
2 shared publicationsMarthe-Lise Frantzen
Institute of Experimental Medical Research, Ullevål University Hospital, Oslo, Norway
2 shared publicationsOystein A Vengen
2 shared publications
Latest Publications
- Open Access
- 1 May 2018
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 33 (suppl_1) , i247
FP608SNF472 INHIBITS HUMAN AORTIC VALVE CALCIFICATION IN VITRO
INTRODUCTION AND AIMS: Calcification in the cardiovascular system is a complication of several serious disease states, including end-stage renal disease. It has a bad prognosis with increased risk for death. SNF472 is an inhibitor of hydroxyapatite crystallization that is already being developed as a treatment for cardiovascular calcification in end-stage renal disease patients (Phase 2 clinical trial 2016-002834-59, ongoing) and for calciphylaxis (Phase 2 clinical trial 2015-004313-25, finalized). However, the efficacy of SNF472 to inhibit calcification of heart valves has not been previously tested. The aim of this study was to assess the potential ability of SNF472 to inhibit induced calcification in a cell culture model of interstitial cells (VIC) from aortic valve leaflets.
- 1 May 2018
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 33 (suppl_1) , i247
Open AccessFP608SNF472 INHIBITS HUMAN AORTIC VALVE CALCIFICATION IN VITRO
INTRODUCTION AND AIMS: Calcification in the cardiovascular system is a complication of several serious disease states, including end-stage renal disease. It has a bad prognosis with increased risk for death. SNF472 is an inhibitor of hydroxyapatite crystallization that is already being developed as a treatment for cardiovascular calcification in end-stage renal disease patients (Phase 2 clinical trial 2016-002834-59, ongoing) and for calciphylaxis (Phase 2 clinical trial 2015-004313-25, finalized). However, the efficacy of SNF472 to inhibit calcification of heart valves has not been previously tested. The aim of this study was to assess the potential ability of SNF472 to inhibit induced calcification in a cell culture model of interstitial cells (VIC) from aortic valve leaflets.
- Open Access
- 1 January 2012
- Published by Springer Nature in World Journal of Emergency Surgery
- Vol. 7 (1) , 17
How to mend a broken heart: a major stab wound of the left ventricle
A 28-year-old male admitted with a stab wound under his left nipple, underwent emergency surgery because of confusion, a decreasing blood pressure and increasing tachycardia. A median sternotomy incision was made and after establishing cardiopulmonary bypass, a 7 cm wound in the left ventricle and a smaller wound in the left atrium were repaired. An injured segment of lung was resected and the left anterior descending and circumflex arteries were grafted after weaning from cardiopulmonary bypass was initially unsuccessful. Although the patient suffered a stroke, probably due to prehospital hypoperfusion, he eventually recovered without major sequelae. In addition to the case report we present a literature review of the last 15 years pertaining the management of penetrating cardiac injury.
- 1 January 2012
- Published by Springer Nature in World Journal of Emergency Surgery
- Vol. 7 (1) , 17
Open AccessHow to mend a broken heart: a major stab wound of the left ventricle
A 28-year-old male admitted with a stab wound under his left nipple, underwent emergency surgery because of confusion, a decreasing blood pressure and increasing tachycardia. A median sternotomy incision was made and after establishing cardiopulmonary bypass, a 7 cm wound in the left ventricle and a smaller wound in the left atrium were repaired. An injured segment of lung was resected and the left anterior descending and circumflex arteries were grafted after weaning from cardiopulmonary bypass was initially unsuccessful. Although the patient suffered a stroke, probably due to prehospital hypoperfusion, he eventually recovered without major sequelae. In addition to the case report we present a literature review of the last 15 years pertaining the management of penetrating cardiac injury.
- Open Access
- 1 May 2010
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 10 (5) , 743-748
Postconditioning in mouse hearts is inhibited by blocking the reverse mode of the sodium–calcium exchanger☆
Ischemic postconditioning and inhibition of the reverse mode of the sodium–calcium exchanger (NCX) are both cardioprotective. We hypothesized that a combination of these techniques might have an additive effect mediated by protein kinases (see below). Isolated perfused mouse hearts were subjected to 35 min of ischemia and 60 min of reperfusion. Each series had its own control ischemia group, the other groups were postconditioning with three cycles of 10 s of reperfusion and 10 s of ischemia immediately after sustained ischemia; the vehicle of the NCX blocker KB-R7943 was added to the perfusate 5 min before ischemia in series 1; KB-R7943 was added to the perfusate 5 min before ischemia with and without postconditioning in series 2; KB-R7943 was added to the perfusate for 5 min from the start of reperfusion with and without postconditioning in series 3. Infarct size was measured and cardiac function was evaluated. Phosphorylation of AKT, ERK1/2, PKCδ and PKCɛ was measured by immunoblotting. Postconditioning alone reduced infarct size by 37% and activated AKT (P=0.02). Blockade of NCX reduced infarct size when applied before ischemia (29%) and at start of reperfusion (32%). Combining NCX blockade with postconditioning abolished cardioprotection despite phosphorylation of ERK1/2 (P=0.03) and PKCɛ (P=0.01).
- 1 May 2010
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 10 (5) , 743-748
Open AccessPostconditioning in mouse hearts is inhibited by blocking the reverse mode of the sodium–calcium exchanger☆
Ischemic postconditioning and inhibition of the reverse mode of the sodium–calcium exchanger (NCX) are both cardioprotective. We hypothesized that a combination of these techniques might have an additive effect mediated by protein kinases (see below). Isolated perfused mouse hearts were subjected to 35 min of ischemia and 60 min of reperfusion. Each series had its own control ischemia group, the other groups were postconditioning with three cycles of 10 s of reperfusion and 10 s of ischemia immediately after sustained ischemia; the vehicle of the NCX blocker KB-R7943 was added to the perfusate 5 min before ischemia in series 1; KB-R7943 was added to the perfusate 5 min before ischemia with and without postconditioning in series 2; KB-R7943 was added to the perfusate for 5 min from the start of reperfusion with and without postconditioning in series 3. Infarct size was measured and cardiac function was evaluated. Phosphorylation of AKT, ERK1/2, PKCδ and PKCɛ was measured by immunoblotting. Postconditioning alone reduced infarct size by 37% and activated AKT (P=0.02). Blockade of NCX reduced infarct size when applied before ischemia (29%) and at start of reperfusion (32%). Combining NCX blockade with postconditioning abolished cardioprotection despite phosphorylation of ERK1/2 (P=0.03) and PKCɛ (P=0.01).
- 1 May 2009
- Vol. 18 (3) , 345-6
Traumatic aortic valve rupture after a high-speed motor-vehicle accident: case report.
The case is reported of a 32-year-old male with an aortic valve injury received in a high-speed traffic accident. Several non-cardiac concomitant injuries were present, none of them life-threatening. Cardiac surgery was performed on day 2 due to a grade III aortic valve insufficiency. The presence of a large tear of the non-coronary cusp, and several concomitant injuries, led to valve replacement being considered the most optimal treatment for this patient.
- 1 May 2009
- Vol. 18 (3) , 345-6
Traumatic aortic valve rupture after a high-speed motor-vehicle accident: case report.
The case is reported of a 32-year-old male with an aortic valve injury received in a high-speed traffic accident. Several non-cardiac concomitant injuries were present, none of them life-threatening. Cardiac surgery was performed on day 2 due to a grade III aortic valve insufficiency. The presence of a large tear of the non-coronary cusp, and several concomitant injuries, led to valve replacement being considered the most optimal treatment for this patient.
- 1 September 2008
- Vol. 17 (5) , 586-8
Traumatic aortic valve rupture after a high-speed motor vehicle accident.
The case is reported of a 32-year-old male who sustained an aortic valve injury after a high-speed traffic accident. Several non-cardiac concomitant injuries were present, none of which was life-threatening. Cardiac surgery was performed on day 2 due to a grade III aortic valve insufficiency. As a large tear of the non-coronary cusp was evident, together with several concomitant injuries, valve replacement was considered to be the most optimal treatment in this case.
- 1 September 2008
- Vol. 17 (5) , 586-8
Traumatic aortic valve rupture after a high-speed motor vehicle accident.
The case is reported of a 32-year-old male who sustained an aortic valve injury after a high-speed traffic accident. Several non-cardiac concomitant injuries were present, none of which was life-threatening. Cardiac surgery was performed on day 2 due to a grade III aortic valve insufficiency. As a large tear of the non-coronary cusp was evident, together with several concomitant injuries, valve replacement was considered to be the most optimal treatment in this case.
- Open Access
- 1 March 2008
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 33 (3) , 355-363
Preconditioning effects of steroids and hyperoxia on cardiac ischemia–reperfusion injury and vascular reactivity☆
Objective: Corticosteroids and hyperoxia protect the heart against ischemia–reperfusion injury and may attenuate vascular reactivity. We hypothesized that (1) combining these two pretreatments induces an additive cardioprotection, (2) protection depends on activation of survival kinases and/or heat shock proteins, and (3) these interventions would change vascular reactivity into a more relaxed state. Methods: Male rats were randomized (n = 10 in each group): 1. control, 2. dexamethasone (3 mg/kg) injected 24 and 12 h before harvesting the hearts, 3. 60 min of hyperoxia (90–95% O2) immediately before harvest, 4. combination of dexamethasone and hyperoxia as in groups 2 and 3. The hearts were Langendorff-perfused and exposed to 30 min of global ischemia and reperfused for 120 min. Cardiac function was monitored and infarct size determined. Isometric tension to vasoconstrictive and vasodilatory agents was measured in femoral artery rings. Phosphorylation of survival kinases (protein kinase B/AKT, extracellular signal-regulated kinases (ERK1/2), the stress-activated/c-Jun NH2 terminal kinases (SAPK/JNK) and p38 MAPK), adenosine monophosphate dependent kinase (AMPK) and expression of heat shock protein 72 (HSP72) in hearts was evaluated by immunoblotting. Results: Infarct size was attenuated in all pretreated groups versus controls: 29% reduction in the combined group (p < 0.01), 23% in hyperoxia group (p < 0.05) and 31% in dexamethasone group (p < 0.01). There was no significant difference between the treated groups. Combined pretreatment improved postischemic left ventricular end diastolic pressure compared to all other groups (p < 0.001 vs controls, p = 0.002 vs dexamethasone, p = 0.005 vs hyperoxia). Combined pretreatment improved left ventricular developed pressure and coronary flow compared to controls (p < 0.001 for both) and hyperoxia (p = 0.0047 and p = 0.0024, respectively). Combined pretreatment enhanced endothelium-independent relaxation (p = 0.0032) compared to controls. Excepting ERK1/2 phosphorylation in the combined group during early reperfusion, there was no increased phosphorylation of the survival kinases AKT, p38, JNK, or AMPK and no increase of HSP72 expression. Conclusion: Combined pretreatment by hyperoxia and dexamethasone improved postischemic heart function, but did not reduce infarct size compared to single pretreatment groups. Except of a possible role of ERK1/2, protection depended neither on survival kinases nor heat shock protein 72.
- 1 March 2008
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 33 (3) , 355-363
Open AccessPreconditioning effects of steroids and hyperoxia on cardiac ischemia–reperfusion injury and vascular reactivity☆
Objective: Corticosteroids and hyperoxia protect the heart against ischemia–reperfusion injury and may attenuate vascular reactivity. We hypothesized that (1) combining these two pretreatments induces an additive cardioprotection, (2) protection depends on activation of survival kinases and/or heat shock proteins, and (3) these interventions would change vascular reactivity into a more relaxed state. Methods: Male rats were randomized (n = 10 in each group): 1. control, 2. dexamethasone (3 mg/kg) injected 24 and 12 h before harvesting the hearts, 3. 60 min of hyperoxia (90–95% O2) immediately before harvest, 4. combination of dexamethasone and hyperoxia as in groups 2 and 3. The hearts were Langendorff-perfused and exposed to 30 min of global ischemia and reperfused for 120 min. Cardiac function was monitored and infarct size determined. Isometric tension to vasoconstrictive and vasodilatory agents was measured in femoral artery rings. Phosphorylation of survival kinases (protein kinase B/AKT, extracellular signal-regulated kinases (ERK1/2), the stress-activated/c-Jun NH2 terminal kinases (SAPK/JNK) and p38 MAPK), adenosine monophosphate dependent kinase (AMPK) and expression of heat shock protein 72 (HSP72) in hearts was evaluated by immunoblotting. Results: Infarct size was attenuated in all pretreated groups versus controls: 29% reduction in the combined group (p < 0.01), 23% in hyperoxia group (p < 0.05) and 31% in dexamethasone group (p < 0.01). There was no significant difference between the treated groups. Combined pretreatment improved postischemic left ventricular end diastolic pressure compared to all other groups (p < 0.001 vs controls, p = 0.002 vs dexamethasone, p = 0.005 vs hyperoxia). Combined pretreatment improved left ventricular developed pressure and coronary flow compared to controls (p < 0.001 for both) and hyperoxia (p = 0.0047 and p = 0.0024, respectively). Combined pretreatment enhanced endothelium-independent relaxation (p = 0.0032) compared to controls. Excepting ERK1/2 phosphorylation in the combined group during early reperfusion, there was no increased phosphorylation of the survival kinases AKT, p38, JNK, or AMPK and no increase of HSP72 expression. Conclusion: Combined pretreatment by hyperoxia and dexamethasone improved postischemic heart function, but did not reduce infarct size compared to single pretreatment groups. Except of a possible role of ERK1/2, protection depended neither on survival kinases nor heat shock protein 72.
- 1 May 2006
- Published by Hindawi Limited in Journal of Cardiac Surgery
- Vol. 21 (3) , 301-303
Cardiac Tamponade Caused by Acute Spontaneous Coronary Artery Rupture
Acute spontaneous coronary artery rupture is rare and the diagnosis might be missed due to high risk of mors subita. We present three patients hospitalized with signs of cardiac tamponade due to acute spontaneous coronary artery rupture. All the three were successfully operated with evacuation of the pericardial hematoma, identification of the bleeding site, and hemostasis. The patients were examined with coronary angiography and computer tomography, and no underlying cause of the rupture was detected. In patients presenting with cardiac tamponade, acute spontaneous coronary artery rupture is a possible diagnosis.
- 1 May 2006
- Published by Hindawi Limited in Journal of Cardiac Surgery
- Vol. 21 (3) , 301-303
Cardiac Tamponade Caused by Acute Spontaneous Coronary Artery Rupture
Acute spontaneous coronary artery rupture is rare and the diagnosis might be missed due to high risk of mors subita. We present three patients hospitalized with signs of cardiac tamponade due to acute spontaneous coronary artery rupture. All the three were successfully operated with evacuation of the pericardial hematoma, identification of the bleeding site, and hemostasis. The patients were examined with coronary angiography and computer tomography, and no underlying cause of the rupture was detected. In patients presenting with cardiac tamponade, acute spontaneous coronary artery rupture is a possible diagnosis.
- 1 January 2006
- Published by Taylor & Francis in Scandinavian Cardiovascular Journal
- Vol. 40 (6) , 334-341
Postconditioning in rats and mice
Objective. For subsequent studies on the molecular mechanisms of postconditioning, we aimed to identify a robust postconditioning protocol in rat and mouse heart. Design. Isolated rat hearts were subjected to different postconditioning protocols (study 1 and 2). The protection was compared to preconditioning. Rats (study 3) in vivo in two different laboratories were postconditioned. Isolated mouse hearts (study 4) and mice in vivo (study 5) were postconditioned. Results. Postconditioning did not protect isolated, perfused rat hearts, however, preconditioning improved function and reduced infarct size. Postconditioning tended to protect rat hearts in vivo in one laboratory (p = 0.10), whereas protection was seen in the other laboratory (infarct size 51±11% vs controls 62±3%, p = 0.01). Postconditioned mouse hearts were protected, both ex vivo (16±9% vs controls 33±18%, p = 0.02) and in vivo (21±5% vs 42±7%, p < 0.001). Conclusions. Rat hearts are less suitable for studies of mechanisms of postconditioning. The results suggest that the signaling pathways differ between pre- and postconditioning. Mouse hearts were strongly protected by postconditioning, and genetically engineered mice may be useful for postconditioning research.
- 1 January 2006
- Published by Taylor & Francis in Scandinavian Cardiovascular Journal
- Vol. 40 (6) , 334-341
Postconditioning in rats and mice
Objective. For subsequent studies on the molecular mechanisms of postconditioning, we aimed to identify a robust postconditioning protocol in rat and mouse heart. Design. Isolated rat hearts were subjected to different postconditioning protocols (study 1 and 2). The protection was compared to preconditioning. Rats (study 3) in vivo in two different laboratories were postconditioned. Isolated mouse hearts (study 4) and mice in vivo (study 5) were postconditioned. Results. Postconditioning did not protect isolated, perfused rat hearts, however, preconditioning improved function and reduced infarct size. Postconditioning tended to protect rat hearts in vivo in one laboratory (p = 0.10), whereas protection was seen in the other laboratory (infarct size 51±11% vs controls 62±3%, p = 0.01). Postconditioned mouse hearts were protected, both ex vivo (16±9% vs controls 33±18%, p = 0.02) and in vivo (21±5% vs 42±7%, p < 0.001). Conclusions. Rat hearts are less suitable for studies of mechanisms of postconditioning. The results suggest that the signaling pathways differ between pre- and postconditioning. Mouse hearts were strongly protected by postconditioning, and genetically engineered mice may be useful for postconditioning research.